MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Designing Healthcare Facilities for Pediatric and Geriatric Populations
Understanding the nuanced needs of both age groups is essential to creating supportive multi-generational environments.
Kaiser Permanente Announces New Hospital Tower at Sunnyside Medical Center
It plans to open this new facility on the campus in 2029.
Building Disaster Resilience Through Collaboration
The ability to respond quickly and recover effectively depends on the strength of an organization’s external bonds.
Amae Health Expands to New York City
This expansion brings its integrated care model to serve individuals with complex mental health conditions.
Hospital for Special Surgery Opens Two New Facilities in New Jersey
The two facilities are a full-service outpatient center and a surgery center.